Nigeria, Pakistan sign pharmaceutical trade agreements

The agreements were signed on the last day of the second Pakistan-Africa Trade Development Conference and Single Country Exhibition.

0
Babajide Sanwo-Olu at the Pakistan-Africa Trade Development Conference and Single Country Exhibition

Nigeria and Pakistan have signed trade agreements on affordable cardiovascular pharmaceuticals and other antibiotics at the ongoing trade exhibition by Pakistani companies in Lagos.

The agreements were signed on the last day of the second Pakistan-Africa Trade Development Conference and Single Country Exhibition.

After signing the deal, the Deputy Managing Director, Assene Laborex Eurapharma, Renaud Beauchamp, disclosed that quality cardiovascular drugs and antibiotics were important for effectively treating diseases in Nigeria.

He added that the Memorandum of Understanding (MoU) between his firm and the Pakistani counterpart had offered Nigerian consumers access to quality and affordable pharmaceuticals.

“They are very affordable quality products for specialists to treat cardiovascular diseases and other ailments,” he said.

Ohgenevwogaga Uti, franchise head of the Assene Laborex Eurapharma, explained that the MoU was an opportunity to import quality affordable drugs for cardiovascular and other diseases.

Mr Uti added that it would boost access to quality treatment of cardiovascular diseases in Nigeria.

“This relationship is going to bring positivity for Nigeria and also create good health care for the people,” he said.

Muhammad Hashmi, director of marketing at International Markets, PharmEvo (Pvt) Ltd, the Pakistani counterpart, noted that Nigeria was a growing market for cardiovascular diseases and other chronic ailments hence the need for quality affordable medicine.

Mr Hashmi explained that the price advantage would help curb the prevalence of hypertension and stroke in Nigeria.

READ ALSO:https://brandpowerng.com/insecurity-undp-presents-draft-bill-to-establish-peace-agency-to-benue-assembly/

In another development, the Senegal representative, Niang Seydou, the CEO of SN International Middle East-Dubai Ajman FZE, signed an MoU with another pharmaceutical company from Pakistan.

During the signing of the MoU, Abdul Razak Dawood, the advisor to the Pakistani Prime Minister on Commence and Investment, stood as a witness.

Mr Dawood stated that the MoU was a sign of commitment from both parties, pointing out that both countries would benefit immensely.

Hundred 100 companies are participating in the exhibition that features sectors like pharmaceutical, paints, and chemicals.

The Pakistan-Africa Trade Development Conference will end today.

(NAN)

You might also like

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More